Julie B. Dumond
机构：University of North Carolina at Chapel Hill, University of North Carolina Health Care · ORCID：0000-0002-3500-5819
发表论文 105 篇 · 总被引 1333 次 · h-index 19
代表论文
- Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial (2024 · The Lancet HIV · 被引 12)
- Noninvasive Markers of Hepatic Steatosis and Fibrosis Following Integrase Strand-Transfer Inhibitor Initiation in Women With HIV (2025 · Clinical Infectious Diseases · 被引 8)
- Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial (2025 · The Lancet HIV · 被引 6)
- Population Pharmacokinetics of Caffeine in Infants with Hypoxic‐Ischemic Encephalopathy: A Phase I, Dose‐Escalating Trial (2025 · The Journal of Clinical Pharmacology · 被引 6)
- A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation (2024 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 3)
- Optimizing On-Demand Tenofovir Disoproxil Fumarate/Emtricitabine Dosing in Women for HIV Prevention (2025 · The Journal of Infectious Diseases · 被引 1)